ConductScience.org, home

Paper26927331

Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors.

Bady P and 2 others. J Mol Diagn, 2016. Cited by 105 papers, by iCite.

Cite this record

ConductScience Library. Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors. Papers, record 26927331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26927331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors.
PubMed
Journal
J Mol Diagn
PubMed
Year
2016
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
105
iCite
Relative citation ratio, by iCite
3.03
iCite
Revised in PubMed
2022-03-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bady PPierre
2Delorenzi MMauro
3Hegi MEMonika E

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
DNA MethylationMajor topic
DNA Modification MethylasesMajor topic
DNA Repair EnzymesMajor topic
EpigenomicsMajor topic
GenomicsMajor topic
GliomaMajor topic
Tumor Suppressor ProteinsMajor topic
Biomarkers
DNA Copy Number Variations
Gene Expression
Humans
Promoter Regions, Genetic
Reference Standards
Reproducibility of Results
Sensitivity and Specificity

Source PubMed

Download CSV of topics

Cited by85

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMIDTitleJournalYearIn PapersSource
42974348DNA methylation in glioma: clinical biomarkers and emerging biosensor-based diagnostics.Front Oncol2026https://conductscience.org/library/papers/42974348PubMed
42867718MGMT promoter methylation as a molecular biomarker in neuro-oncology: current practices, challenges, and future directions.J Neurooncol2026https://conductscience.org/library/papers/42867718PubMed
42747321High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort.Neuro Oncol2026https://conductscience.org/library/papers/42747321PubMed
42630077DNA Methylation Profiling in IDH-Mutant Gliomas: Biological Evolution, Molecular Grading and Clinical Implementation.Neuropathol Appl Neurobiol2026https://conductscience.org/library/papers/42630077PubMed
41770225Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response.Acta Neuropathol2026https://conductscience.org/library/papers/41770225PubMed
41649072Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalities.Brain Pathol2026https://conductscience.org/library/papers/41649072PubMed
41460180Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas.Neuro Oncol2026https://conductscience.org/library/papers/41460180PubMed
40779733Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.J Clin Oncol2025https://conductscience.org/library/papers/40779733PubMed
40735274Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors.Neurooncol Adv2025https://conductscience.org/library/papers/40735274PubMed
40504671FGFR1 fusions in genomically and epigenetically bona fide glioblastoma, IDH-wildtype.J Neuropathol Exp Neurol2026https://conductscience.org/library/papers/40504671PubMed
40464417Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma.Mol Cancer Ther2025https://conductscience.org/library/papers/40464417PubMed
40444102Defining the recommended gray zone in O6-methylguanine-DNA methyltransferase promoter methylation pyrosequencing reporting: A robust, translatable method to implement new EANO guidelines.Neurooncol Adv2025https://conductscience.org/library/papers/40444102PubMed
40420192Tumour-associated macrophage infiltration differs in meningioma genotypes, and is important in tumour dynamics.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40420192PubMed
40313597CEBPA-associated familial acute myeloid leukemia mimicking Werner syndrome: a case report.Front Genet2025https://conductscience.org/library/papers/40313597PubMed
40075518SNUH methylation classifier for CNS tumors.Clin Epigenetics2025https://conductscience.org/library/papers/40075518PubMed
40041202Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment.Neurooncol Adv2025https://conductscience.org/library/papers/40041202PubMed
39992425Predictive modeling with linear machine learning can estimate glioblastoma survival in months based solely on MGMT-methylation status, age and sex.Acta Neurochir (Wien)2025https://conductscience.org/library/papers/39992425PubMed
39902391cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics.Neurooncol Adv2025https://conductscience.org/library/papers/39902391PubMed
39901324Peripheral blood-derived immune cell counts as prognostic indicators and their relationship with DNA methylation subclasses in glioblastoma patients.Brain Pathol2025https://conductscience.org/library/papers/39901324PubMed
39881389Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients.Clin Epigenetics2025https://conductscience.org/library/papers/39881389PubMed

See all 85 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MGMT4255PubTator's text mininghttps://conductscience.org/library/genes/4255

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26927331

GET https://conductscience.org/api/papers/v1/26927331/cited_by?page=2